- Home
- ZLAB vs PBH Comparison
ZLAB vs PBH Comparison
Compare ZLAB & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- PBH
- Stock Information
- Founded
- ZLAB 2013
- PBH 1996
- Country
- ZLAB China
- PBH United States
- Employees
- ZLAB N/A
- PBH N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- PBH Biotechnology: Pharmaceutical Preparations
- Sector
- ZLAB Health Care
- PBH Health Care
- Exchange
- ZLAB Nasdaq
- PBH Nasdaq
- Market Cap
- ZLAB 3.6B
- PBH 4.2B
- IPO Year
- ZLAB 2017
- PBH 2005
- Fundamental
- Price
- ZLAB $32.54
- PBH $76.33
- Analyst Decision
- ZLAB Buy
- PBH Buy
- Analyst Count
- ZLAB 5
- PBH 5
- Target Price
- ZLAB $54.28
- PBH $94.00
- AVG Volume (30 Days)
- ZLAB 781.8K
- PBH 404.5K
- Earning Date
- ZLAB 08-05-2025
- PBH 08-07-2025
- Dividend Yield
- ZLAB N/A
- PBH N/A
- EPS Growth
- ZLAB N/A
- PBH 2.88
- EPS
- ZLAB N/A
- PBH 4.29
- Revenue
- ZLAB $418,326,000.00
- PBH $1,137,762,000.00
- Revenue This Year
- ZLAB $44.07
- PBH $2.04
- Revenue Next Year
- ZLAB $49.13
- PBH $2.07
- P/E Ratio
- ZLAB N/A
- PBH $17.89
- Revenue Growth
- ZLAB 43.72
- PBH 1.10
- 52 Week Low
- ZLAB $16.01
- PBH $64.94
- 52 Week High
- ZLAB $44.34
- PBH $90.04
- Technical
- Relative Strength Index (RSI)
- ZLAB 40.19
- PBH 24.77
- Support Level
- ZLAB $34.26
- PBH $78.86
- Resistance Level
- ZLAB $35.72
- PBH $80.69
- Average True Range (ATR)
- ZLAB 1.12
- PBH 1.69
- MACD
- ZLAB -0.54
- PBH -0.45
- Stochastic Oscillator
- ZLAB 3.83
- PBH 6.78
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.